![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Paraneoplastic Syndromes - 51 Studies Found
Completed |
: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes : Congenital Myasthenic Syndrome : 2010-09-15 : Drug: Albuterol 4 mg twice daily by mouth for adults. The dose for children 6 to 12 years is 2 mg two or |
Available |
: Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine : Lambert-Eaton Myasthenic Syndrome : 2009-10-08 : Drug: 3,4 diaminopyridine 3,4 diaminopyridine up to 80 mg daily in divided doses |
Recruiting |
: 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS) :
: 2009-03-30 :
|
Available |
: Treatment of Lambert-Eaton Syndrome With 3,4 DAP : Lambert Eaton Myasthenic Syndrome : 2008-06-23 : Drug: 3, 4 DAP Patients with clinically-confirmed LEMS will receive 3, 4 DAP by mouth in slowly increasi |
Completed |
: Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome : Lambert-Eaton Myasthenic Syndrome : 2000-02-24 : Drug: 3,4-diaminopyridine |
Completed |
: Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in Beijing Area : Anti-N-Methyl-D-Aspartate Receptor Encephalitis : 2015-05-10 |
Completed |
: Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Anti-NMDA Receptor Encephalitis : Anti-NMDA Receptor Encephalitis : 2013-05-21 :
|
Recruiting |
: Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate or CAPTURE Study : Myelitis, Transverse : 2014-05-19 |
Terminated |
: IVIG Treatment for Refractory Immune-Related Adult Epilepsy :
|
Recruiting |
: Central Pain Study for ABX-1431 :
: |